Advocacy intelligence hub — real-time data for patient organizations
Ascor: FDA approved
for the treatment of scurvy in adult and pediatric patients age 5 months and older for whom oral administrtaion is not possible, insufficient or contraindicated
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Ascor
McGuff Pharmaceuticals Inc.